Supply Chain/Technology

Latest Issue of OR Manager
October 2018
Home Supply Chain/Technology

ECRI Institute reports on Health Devices Achievement Award recipient

Editor's Note In its July Health Technology eSource, ECRI Institute reported on Boston Medical Center winning the 2018 Health Devices Achievement Award for its pulmonary care app. The ICOUGH Recovery app promotes better engagement with and adherence to the hospital’s recommended postoperative pulmonary care protocol, which focuses on: (I)ncentive spirometry…

Read More

By: Judy Mathias
July 11, 2018
Share

Report predicts growth for spinal fusion market

Editor's Note An Acquire Market Research report predicts the global spinal fusion market will grow at a 4.54% compound annual growth rate through 2023, according to the June 21 Becker’s Spine Review. Reasons for the predicted growth are the: growing incidence of spinal deformity cases rising healthcare awareness increase in…

Read More

By: Judy Mathias
June 25, 2018
Share

Robot-assisted vs open cystectomy

Editor's Note Robot-assisted and open cystectomies are equally effective in treating bladder cancer, this 7-year study finds. Conducted at 17 institutions, 350 patients with bladder cancer were randomized to the open (175 patients) or the robot-assisted (175 patients) surgical approach. The researchers found lower blood loss and transfusion rates and…

Read More

By: Judy Mathias
June 22, 2018
Share

Effectiveness of reprocessing reusable flexible bronchoscopes

Editor's Note In a study on the effectiveness of reprocessing flexible bronchoscopes presented June 14 by Ofstead and Associates at the Association for Professionals in Infection Control’s annual conference in Minneapolis, the majority of bronchoscopes were found to be contaminated and damaged even when cleaned and high-level disinfected according to…

Read More

By: Judy Mathias
June 20, 2018
Share

FDA letter updates risks of Type III endoleaks with aortic endovascular graft systems

Editor's Note In a June 19 letter to healthcare providers, the Food & Drug Administration (FDA) says it continues to evaluate information from several sources, including manufacturers, on the risks associated with Type III endoleaks with various endovascular graft systems used for treatment of abdominal aortic aneurysms (AAAs) and aorto-iliac…

Read More

By: Judy Mathias
June 20, 2018
Share

Cybersecurity should be high on healthcare priority lists

No homeowners willingly allow a burglar to enter their home and steal their most valuable possessions. Instead, people put locks on doors, install alarm systems, build fences, or keep big dogs. The thieves may still get in, but deterrents like these will reduce the risk of a successful burglary. Ambulatory…

Read More

By: Janet M. Boivin, BSN, BSJ, RN
June 20, 2018
Share

Machine-learning algorithm predicts hypotension during surgery

Editor's Note In this study, researchers at UCLA Medical Center in Los Angeles applied machine learning to arterial pressure waveforms to develop an algorithm that predicted intraoperative hypotension 15 minutes before it occurred in 84% of cases. Two sets of data were used to build the algorithm. One set consisted…

Read More

By: Judy Mathias
June 12, 2018
Share

FDA: Hospira recalls two lots of Naloxone Hydrochloride Injection

Editor's Note The Food & Drug Administration on June 4 announced the recall by Hospira, Inc, of two lots of its opioid antagonist Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69). The two lots, 72680LL and 76510LL, were recalled because…

Read More

By: Judy Mathias
June 11, 2018
Share

FDA issues Class I Recall of CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope

Editor's Note The Food & Drug Administration on June 6 identified the recall by Maquet Datascope Corp of its CARDIOSAVE Hybrid Intra-aortic Balloon Pump as Class I, the most serious. The recall was initiated because of a design issue that allows fluid to seep into the device, which can lead…

Read More

By: Judy Mathias
June 7, 2018
Share

Study: Medical device tax hurts investment in R&D

Editor's Note: This study from Iowa State University shows companies have cut funding for research and development (R&D) in response to the medical device tax imposed by the Affordable Care Act. Since 2013, the 2.3% excise tax has significantly reduced: R&D investment by $34 million Sales revenue by $188 million…

Read More

By: Judy Mathias
June 6, 2018
Share
Live chat by BoldChat